Search Within

Evan Rosenbaum

Formats
  1. Journal Article (28)
  2. Meeting Abstract (24)
  3. Correspondence (1)
Groups
  1. Department of Medicine (53)
  2. Sarcoma Service (53)
  3. Solid Tumor Oncology Division (53)
  4. Weinberg Fellows (53)
  5. Hematologic Malignancies, Division of (45)
  6. GSK Faculty (41)

More Groups

People
  1. William Tap (45)
  2. Sandra D'Angelo (44)
  3. Ciara Kelly (36)
  4. Ping Chi (36)
  5. Mark Dickson (35)
  6. Mary Keohan (33)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (11)
  4. 2022 (16)
  5. 2021 (4)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Clinical Cancer Research (8)
  3. Annals of Oncology (5)
  4. JCO Precision Oncology (3)
  5. American Journal of Surgical Pathology (2)
  6. ESMO Open (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (20)
  2. American Association for Cancer Research (9)
  3. Oxford University Press (6)
  4. Elsevier Inc. (3)
  5. Nature Publishing Group (3)
  6. Biomed Central Ltd (2)

More Publishers

Results (53)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
    Journal Article

    Movva, S.; Seier, K.; Bradic, M.; Charalambous, K.; Rosenbaum, E.; Kelly, C. M.; Cohen, S. M.; Hensley, M. L.; Avutu, V.; Banks, L. B.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade
    Journal Article

    Babatunde, O. O.; Membribes, S. C.; Anthonescu, C.; Bradic, M.; O'Malley, B.; Linkov, I.; Bartlett, E.; Momtaz, P.; Alektiar, K.; Gounder, M. M.; more...
    npj Precision Oncology (2025)

    Fulltext@MSK | Save
  • International multicenter retrospective study from the Ultra-rare Sarcoma Working Group on low-grade fibromyxoid sarcoma, sclerosing epithelioid fibrosarcoma, and hybrid forms
    Journal Article

    Giani, C.; Salawu, A.; Ljevar, S.; Denu, R. A.; Napolitano, A.; Palmerini, E.; Connolly, E. A.; Ogura, K.; Wong, D. D.; Scanferla, R.; more...
    American Journal of Surgical Pathology (2025)

    Fulltext@MSK | Save
  • Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
    Meeting Abstract

    Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A retrospective single-center study of outcomes to immune checkpoint blockade-based therapy in leiomyosarcoma
    Meeting Abstract

    Babatunde, O.; Rosenbaum, E.; Kelly, C. M.; Desir-Camille, R.; Keohan, M. L.; Banks, L.; Avutu, V.; Chan, J.; Reed, D.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Histology-specific clinical trial of lenvatinib and pembrolizumab in patients with sarcoma
    Journal Article

    Movva, S.; Seier, K.; Avutu, V.; Banks, L. B.; Chan, J.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: Retrospective study from the Ultra-Rare Sarcoma Working Group
    Journal Article

    Giani, C.; Denu, R. A.; Ljevar, S.; Gronchi, A.; Napolitano, A.; Rosenbaum, E.; Salawu, A.; Bajpai, J.; Connolly, E. A.; Lee, A. T. J.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save
  • Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save